查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405911

花生过敏治疗市场规模、份额、趋势分析报告：按药物类别、给药途径、配销通路管道、地区和细分市场预测，2024-2030 年

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

花生过敏治疗市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球花生过敏治疗市场规模预计将达到 10.1 亿美元。

预计2024年至2030年该市场将以11.82%的复合年增长率成长。推动市场成长的关键因素包括强大的产品平臺、高疾病盛行率、药物输送系统的进步以及主要企业的策略性倡议。

市场主要企业正在透过各种策略加强其花生过敏治疗管道。例如，Aravax 于 2022 年 12 月启动了 B 轮资金筹措，获得了澳洲着名医疗保健企业家 Tenmile 和 Brandon Capital 的 2,000 万美元投资。这笔资金筹措将使 Aravax 能够在对花生过敏的人群中开始 PVX108 的 II 期临床试验。此类资金筹措预计将推进研究和开发计划。

花生过敏药物核准数量的增加也刺激了市场。 2020年1月，美国食品药物管理局（FDA）批准了由Aimmune Therapeutics, Inc.开发的PALFORZIA [花生（花生）过敏原粉-dnfp]。 PALFORZIA 是第一个核准用于花生过敏患者的免疫疗法。该药物是一种口服免疫治疗剂，旨在减轻因意外摄入花生而引起的过敏反应，包括过敏反应。该药适用于已确诊过敏的患者，建议 4 至 17 岁儿童增加初始给药。

截至 2023 年第一季，几种有前途的研发线产品正在临床开发中。其中包括 DBV Technologies 的 Viaskin Peanut、Dupixient 的 CA002 以及赛诺菲 (Sanofi) 和 Regeneron 的合作产品 Camallegr。此外，ADP101、VE416、INP20 和 CNP-201 等资产正在开发中。预计这些药物的推出将有助于预测期内的市场成长和扩张。

花生过敏治疗市场报告亮点

  • 2023 年，肾上腺素细分市场占据主要市场占有率。过敏反应的标准治疗方法是肾上腺素自动注射器，这对于紧急过敏管理也至关重要。
  • 从给药途径来看，注射剂在 2023 年占据市场主导地位。这是由于人们越来越重视以患者为中心的护理，以及实用、痛苦较小且更易于患者使用的注射剂市场的开拓。这包括考虑注射疗法的替代输送系统，例如可穿戴技术和自动注射器。
  • 按配销通路，2023年医院药房细分市场占据最大市场占有率。医院药房致力于为花生过敏患者提供支持和资讯。
  • 北美在这个市场上拥有强大的区域地位。这是因为目前有许多製药公司、学术机构和研究机构正在研究解决花生过敏根本原因的新治疗策略，包括生技药品疗法、生物製剂和其他免疫调节干预措施。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场趋势及展望
  • 市场动态
    • 花生过敏治疗药物核准增加
    • 花生过敏盛行率增加
    • 医疗费用增加
  • 市场抑制因素分析
    • 处理成本和产品成本高
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第四章给药途径业务分析

  • 花生过敏治疗市场：给药途径变化分析
  • 口服
  • 可注射的
  • 其他的

第五章医药类业务分析

  • 花生过敏治疗市场：药物类别变异分析
  • 抗组织胺药
  • 肾上腺素
  • 免疫疗法
  • 其他的

第六章配销通路业务分析

  • 花生过敏治疗市场：配销通路波动分析
  • 医院药房
  • 零售药房
  • 其他的

第七章 区域业务分析

  • 2023 年及 2030 年花生过敏治疗市场占有率（按地区）
  • 北美洲
    • SWOT分析
    • 北美花生过敏治疗市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 欧洲花生过敏治疗市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 亚太地区花生过敏治疗市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲花生过敏治疗市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • SWOT分析
    • MEA 花生过敏治疗市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导者
    • 2023 年花生过敏治疗市场占有率占分析
    • 公司简介
    • 策略规划
Product Code: GVR-4-68040-097-6

Peanut Allergy Treatment Market Growth & Trends:

The global peanut allergy treatment market size is expected to reach USD 1.01 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 11.82% from 2024 to 2030. Some of the key factors propelling the market growth include a robust product pipeline, high disease prevalence, advancement in the drug delivery system, and strategic initiatives by key players.

Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.

The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.

As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.

Peanut Allergy Treatment Market Report Highlights:

  • The epinephrine segment held the major market share in 2023. The standard of care for anaphylaxis treatment has been epinephrine auto-injectors, which are also essential in the management of allergies in emergency situations
  • By route of administration, the injectable segment dominated the market in 2023 owing to the development of injectable treatments that are practical, less painful, and easier to use for patients is being pursued in response to the growing emphasis on patient-centered care. This includes looking at alternative delivery systems for injectable therapies, such as wearable technology or auto-injectors
  • By distribution channel, the hospital pharmacy segment held the largest market share in 2023. Hospital pharmacies put more of an emphasis on offering patient support and information for people with peanut allergies
  • North America has established a strong regional position in the market. This is due to the presence of numerous pharmaceutical companies, academic institutions, and research organizations currently looking into new therapeutic strategies to address the underlying causes of peanut allergies, including gene therapy, biologics, and other immunomodulatory interventions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Drug Class and Route of Administration Snapshot
  • 2.3. Distribution Channel Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising product approvals for the treatment of peanut allergy
    • 3.4.2. Increasing prevalence of peanut allergies
    • 3.4.3. Increasing healthcare expenditure
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of the treatment and the products
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Route Of Administration Business Analysis

  • 4.1. Peanut Allergy Treatment Market: Route Of Administration Movement Analysis
  • 4.2. Oral
    • 4.2.1. Oral Market, 2018 - 2030 (USD Million)
  • 4.3. Injectable
    • 4.3.1. Injectable Market, 2018 - 2030 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Drug Class Business Analysis

  • 5.1. Peanut Allergy Treatment Market: Drug Class Movement Analysis
  • 5.2. Antihistamines
    • 5.2.1. Antihistamines Market, 2018 - 2030 (USD Million)
  • 5.3. Epinephrine
    • 5.3.1. Epinephrine Market, 2018 - 2030 (USD Million)
  • 5.4. Immunotherapies
    • 5.4.1. Immunotherapies Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Distribution Channel Business Analysis

  • 6.1. Peanut Allergy Treatment Market: Distribution Channel Movement Analysis
  • 6.2. Hospital Pharmacy
    • 6.2.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3. Retail Pharmacy
    • 6.3.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4. Others
    • 6.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Peanut Allergy Treatment Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Peanut Allergy Treatment Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Peanut Allergy Treatment market, 2018 - 2030 (USD MILLION)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. Germany Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. UK Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. South Korea Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Australia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. Thailand Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Peanut Allergy Treatment market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Peanut Allergy Treatment market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant's overview
  • 8.2. Financial performance
  • 8.3. Participant categorization
    • 8.3.1. Market Leaders
    • 8.3.2. Peanut Allergy Treatment market Share Analysis, 2023
    • 8.3.3. Company Profiles
      • 8.3.3.1. Sanofi
      • 8.3.3.1.1. Company Overview
      • 8.3.3.1.2. Financial Performance
      • 8.3.3.1.3. Product Benchmarking
      • 8.3.3.1.4. Strategic Initiatives
      • 8.3.3.2. Aimmune Therapeutics Inc.
      • 8.3.3.2.1. Company Overview
      • 8.3.3.2.2. Financial Performance
      • 8.3.3.2.3. Product Benchmarking
      • 8.3.3.2.4. Strategic Initiatives
      • 8.3.3.3. DBV Technologies
      • 8.3.3.3.1. Company Overview
      • 8.3.3.3.2. Financial Performance
      • 8.3.3.3.3. Product Benchmarking
      • 8.3.3.3.4. Strategic Initiatives
      • 8.3.3.4. Vedanta Biosciences, Inc.
      • 8.3.3.4.1. Company Overview
      • 8.3.3.4.2. Financial Performance
      • 8.3.3.4.3. Product Benchmarking
      • 8.3.3.4.4. Strategic Initiatives
      • 8.3.3.5. Alladapt Immunotherapeutics, Inc.
      • 8.3.3.5.1. Company Overview
      • 8.3.3.5.2. Financial Performance
      • 8.3.3.5.3. Product Benchmarking
      • 8.3.3.5.4. Strategic Initiatives
      • 8.3.3.6. Regeneron Pharmaceuticals Inc.
      • 8.3.3.6.1. Company Overview
      • 8.3.3.6.2. Financial Performance
      • 8.3.3.6.3. Product Benchmarking
      • 8.3.3.6.4. Strategic Initiatives
      • 8.3.3.7. Aravax Pty Ltd
      • 8.3.3.7.1. Company Overview
      • 8.3.3.7.2. Financial Performance
      • 8.3.3.7.3. Product Benchmarking
      • 8.3.3.7.4. Strategic Initiatives
      • 8.3.3.8. Prota Therapeutics
      • 8.3.3.8.1. Company Overview
      • 8.3.3.8.2. Financial Performance
      • 8.3.3.8.3. Product Benchmarking
      • 8.3.3.8.4. Strategic Initiatives
      • 8.3.3.9. Teva Pharmaceuticals Industries Ltd.
      • 8.3.3.9.1. Company Overview
      • 8.3.3.9.2. Financial Performance
      • 8.3.3.9.3. Product Benchmarking
      • 8.3.3.9.4. Strategic Initiatives
    • 8.3.4. Strategy Mapping
      • 8.3.4.1. Expansion
      • 8.3.4.2. Acquisition
      • 8.3.4.3. Collaborations
      • 8.3.4.4. Route Of Administration/Drug Class Launch
      • 8.3.4.5. Partnerships
      • 8.3.4.6. Others

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 3 Global Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 5 Global Peanut Allergy Treatment Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 8 North America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 9 North America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 11 U.S. Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 12 U.S. Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 14 Canada Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 15 Canada Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Europe Peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 18 Europe peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 19 Europe peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 20 Germany Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 21 Germany Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 22 Germany Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 UK Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 24 UK Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 25 UK Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 France Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 27 France Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 28 France Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 Italy Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 30 Italy Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 31 Italy Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Spain Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 33 Spain Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 34 Spain Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Denmark Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 36 Denmark Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 37 Denmark Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Sweden Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 39 Sweden Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 40 Sweden Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Norway Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 42 Norway Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 43 Norway Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 48 China Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 49 China Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 50 China Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Japan Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 52 Japan Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Japan Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 India Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 55 India Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 56 India Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 South Korea Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 58 South Korea Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 59 South Korea Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 Australia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 61 Australia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Australia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Thailand Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 64 Thailand Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 65 Thailand Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Latin America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 68 Latin America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 69 Latin America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 70 Brazil Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 71 Brazil Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 72 Brazil Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Mexico Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 74 Mexico Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 75 Mexico Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 77 Argentina Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 78 Argentina Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 83 South Africa Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 84 South Africa Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 85 South Africa Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 90 UAE Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 91 UAE Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Peanut allergy treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Route of administration and distribution channel segment snapshot
  • Fig. 11 Drug class segment snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 13 Allergy diagnostics and therapeutics market value, 2023 (USD billion)
  • Fig. 14 Market dynamics
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 PESTLE analysis
  • Fig. 17 KOLs perspective
  • Fig. 18 KOLs perspective
  • Fig. 19 KOLs perspective
  • Fig. 20 Peanut allergy treatment market: Route of administration outlook and key takeaways
  • Fig. 21 Peanut allergy treatment market: Route of administration movement analysis
  • Fig. 22 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Peanut allergy treatment market: Drug class outlook and key takeaways
  • Fig. 26 Peanut allergy treatment market: Drug class movement analysis
  • Fig. 27 Antihistamines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Epinephrine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Immunotherapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Peanut allergy treatment market: Distribution channel outlook and key takeaways
  • Fig. 32 Peanut allergy treatment market: Distribution channel movement analysis
  • Fig. 33 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Peanut allergy treatment market revenue, by region, 2023 & 2030 (USD Million)2023 & 2030 (USD Million)2023 & 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 North America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 U.S. peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. healthcare system: Money flow
  • Fig. 43 Key country dynamics
  • Fig. 44 Canada peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Drug pricing
  • Fig. 65 Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Japan peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Japan pharmaceutical registration
  • Fig. 69 Key country dynamics
  • Fig. 70 China peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Regulatory details: China
  • Fig. 72 Exclusivity formula
  • Fig. 73 Key country dynamics
  • Fig. 74 India peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Registration details: India
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Drug pricing: Australia
  • Fig. 79 Contribution of PBS by disease
  • Fig. 80 Key country dynamics
  • Fig. 81 Thailand peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Korea peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Reimbursement scenario: South Korea
  • Fig. 85 Rest of Asia Pacific peanut allergy treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Mexico peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Regulatory framework
  • Fig. 92 Reimbursement scenario
  • Fig. 93 Key country dynamics
  • Fig. 94 Argentina peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Argentina pharmaceuticals registration details
  • Fig. 96 Argentina pharmaceuticals reimbursement details
  • Fig. 97 Rest of Latin America peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Middle East and Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 South Africa peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Regulatory framework: South Africa
  • Fig. 102 Regulatory framework: South Africa drug registration fees
  • Fig. 103 Key country dynamics
  • Fig. 104 Saudi Arabia peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UAE peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Kuwait peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Regulatory framework: South Africa
  • Fig. 110 Rest of MEA peanut allergy treatment market estimates and forecasts, 2018 - 2030 (USD Million)